The coronavirus disease 2019 pandemic accelerated drug/vaccine development processes,
integrating scientists all over the globe to create therapeutic alternatives against this virus. In …

Abstract The Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus
needs a fast recognition of effective drugs to save lives. In the COVID-19 situation, finding …

Abstract Treatment options for COVID‐19, caused by SARS‐CoV‐2, remain limited.
Understanding viral pathogenesis at the molecular level is critical to develop effective …

To better understand the potential of drug repurposing in COVID-19, we analyzed control
strategies over essential host factors for SARS-CoV-2 infection. We constructed …

Background COVID-19, a pandemic declared by WHO, has infected about 39.5 million and
killed about 1.1 million people throughout the world. There is the urgent need of more …

Abstract Coronavirus Disease-2019 (COVID-19) is an infectious disease caused by the
SARS-CoV-2 virus. Various studies exist about the molecular mechanisms of viral infection …

COVID-19 is a global pandemic impacting the daily living of millions. As variants of the virus
evolve, a complete comprehension of the disease and drug targets becomes a decisive …

Background: Coronavirus (CoV) is an emerging human pathogen causing severe acute
respiratory syndrome (SARS) around the world. Earlier identification of biomarkers for SARS …

Coronavirus-infected diseases have posed great threats to human health. In past years,
highly infectious coronavirus-induced diseases, including COVID-19, SARS, and MERS …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has heavily challenged the
global healthcare system. Despite the vaccination programs, the new virus variants are …